- Open Access
The role of transforming growth factor-beta (TGF-beta) during ovarian follicular development in sheep
Reproductive Biology and Endocrinology volume 2, Article number: 78 (2004)
Recently, several members of the transforming growth factor-beta (TGF-beta) superfamily have been shown to be essential for regulating the growth and differentiation of ovarian follicles and thus fertility.
Ovaries of neonatal and adult sheep were examined for expression of the TGF-betas 1–3 and their receptors (RI and RII) by in situ hybridization using ovine cDNAs. The effects of TGF-beta 1 and 2 on proliferation and differentiation of ovine granulosa cells in vitro were also studied.
The expression patterns of TGF-beta 1 and 2 were similar in that both mRNAs were first observed in thecal cells of type 3 (small pre-antral) follicles. Expression of both mRNAs continued to be observed in the theca of larger follicles and was also present in cells within the stroma and associated with the vascular system of the ovary. There was no evidence for expression in granulosa cells or oocytes. Expression of TGF-beta 3 mRNA was limited to cells associated with the vascular system within the ovary. TGFbetaRI mRNA was observed in oocytes from the type 1 (primordial) to type 5 (antral) stages of follicular growth and granulosa and thecal cells expressed this mRNA at the type 3 (small pre-antral) and subsequent stages of development. The TGFbetaRI signal was also observed in the ovarian stroma and vascular cells. In ovarian follicles, mRNA encoding TGFbetaRII was restricted to thecal cells of type 3 (small pre-antral) and larger follicles. In addition, expression was also observed in some cells of the surface epithelium and in some stromal cells. In granulosa cells cultured for 6 days, both TGF-beta 1 and 2 decreased, in a dose dependent manner, both the amount of DNA and concentration of progesterone.
In summary, mRNA encoding both TGF-beta 1 and 2 were synthesized by ovarian theca, stroma and cells of the vascular system whereas TGF-beta 3 mRNA was synthesized by vascular cells. Luteinizing granulosa cells also responded to both TGF-beta 1 and beta 2 in vitro. These findings in sheep are consistent with TGF-beta potentially being an important autocrine regulator of thecal cell function and possibly a paracrine regulator of ovarian cell function at various development stages.
Members of the transforming growth factor-beta (TGF-β) superfamily are important intraovarian growth factors [1–6]. Three key members of the TGF-β subfamily, namely TGF-β1, TGF-β2 and TGF-β3, have been shown to be produced by ovarian cells [7–13]. However, the cellular distribution of these proteins varies between species. Likewise, the effects of TGF-βs on granulosa cell function also vary between species. In rodents, TGF-βs are potent stimulators of granulosa cell proliferation [14–16] whereas in other species, such as cattle and pigs, these growth factors have only a mild stimulatory or even inhibitory effect [17–20]. Likewise, TGF-βs stimulate progesterone synthesis from rodent granulosa cells [21–23] where inhibitory effects are observed in granulosa cells collected from sheep, cattle and pigs [17, 24–26]. Exceptional ovulation rates and sterility have been observed in lines of sheep with mutations in two members of the TGF-β superfamily, namely growth differentiation factor 9 or bone morphogenetic protein 15 or one of their receptors, activin like kinase-6 [6, 27]. However, little is known about the roles of other members of the TGF-β superfamily in sheep and thus the potential interactions of members of the TGF-β superfamily are unclear. The objectives of this study in sheep were to localize the ovarian cellular types expressing mRNA encoding TGF-β1, TGF-β2, TGF-β3, TGFβRI and TGFβRII and to determine the effects of TGF-β1 and TGF-β2 on granulosa cell proliferation/survival and progesterone production in vitro.
Generation of cDNAs encoding a portion of the coding region of genes of interest
Except where indicated, laboratory chemicals were obtained from BDH Chemicals New Zealand Ltd (Palmerston North, New Zealand), Invitrogen (Auckland, New Zealand) or Roche Diagnostics N.Z. Ltd. (Auckland, New Zealand).
Total cellular RNA was isolated from ovine ovary using TRIzol according to manufacturer's instructions. First strand cDNA was produced from total cellular RNA using a poly t primer. Complementary DNAs encoding a portion of the coding sequence of the genes were isolated using standard PCR techniques. For individual cDNAs generated, primer sequences and annealing temperature are given in table 1. Resulting PCR products were ligated into appropriate vectors and their nucleotide sequence determined by automated sequence analysis (Waikato DNA Sequencing Facility; The University of Waikato; Hamilton, New Zealand). These sequences were compared with known sequences to confirm identity using the GAP program of GCG (Wisconsin Package Version 10.2, Genetics Computer Group; Madison, Wisconsin). All sequences were >80% identical to those listed as reference sequences in table 1 indicating that the ovine homologue of the respective genes had been obtained.
Collection of tissue samples
All experiments were performed in accordance with the 1999 Animal Welfare Act Regulations of New Zealand. All animals had ad lib access to pasture and water and lambs were kept with their mothers until just prior to tissue collection. Romney ewes and lambs were killed by administration of a barbiturate overdose (Pentobarbitone; 200 mg/kg, Southern Veterinary Supplies, Christchurch, New Zealand). Recovered ovaries were fixed in 4% (w/v) phosphate-buffered paraformaldehyde and embedded in paraffin wax.
In Situ Hybridization
Cellular localization of mRNAs was determined using the in situ hybridization protocol described previously with minor modifications . Sense and anti-sense RNA probes were generated from cDNA encoding the gene of interest with T7, T3 or SP6 RNA polymerase using the Riboprobe combination system (Promega, Dade Behring Diagnostics Ltd., Auckland, New Zealand). For all in situ hybridizations, 4–6 μm tissue sections were incubated overnight at 55°C with 45,000 cpm/μl (approximately 48,000 dpm/μl) of 33P-labelled antisense RNA. Non-specific hybridization of RNA was removed by RNase A digestion followed by stringent washes (2 × SSC, 50% formamide, 65°C and 0.2 × SSC at 37°C). Following washing, sections were dehydrated, air dried and coated with autoradiographic emulsion (LM-1 emulsion; Amersham Pharmacia Biotech, New Zealand). Emulsion-coated slides were exposed at 4°C for 3 weeks, developed for 3 1/2 minutes in D19 developer (Eastman Kodak, Rochester, NY), development was stopped using a 1 minute incubation in 1% acetic acid and slides were fixed with a 10 minute incubation in Ilfofix II (Ilford Limited, Cheshire, England). Sections were stained with hematoxylin and then viewed and photographed using both light and dark field illumination on an Olympus BX-50 microscope (Olympus New Zealand Ltd., Lower Hutt, New Zealand). Non-specific hybridization was monitored by hybridizing at least two tissue sections from each age group (lamb and adult) with approximately equal concentrations of the sense RNA for each gene. Hybridization was considered to be specific when the intensity of silver grains, as measured by visual assessment, over a cellular type was greater than that observed in the area of the slide not containing tissue. For all genes, hybridization of the sense RNA over the tissue section was similar or lower in intensity to that observed on the areas of the slide not containing tissue of both the sense and antisense hybridized slides and thus was considered non-specific.
Classification of follicles was based on the system outlined by Lundy et al. . Briefly, type 1/1a follicles consist of an oocyte surrounded by a single layer of flattened or mixed flattened and cuboidal cells. Type 2 follicles contain 1 < 2 layers of cuboidal granulosa cells whereas type 3 follicles contain 2 < 4 layers of cuboidal granulosa cells. Type 4 follicles have >4 layers of granulosa cells and a well defined theca but have not yet formed an antrum. Type 5 follicles have multiple layers of granulosa cells, a well defined theca and a defined antrum. All follicles with signs of degeneration (i.e. pyknotic granulosa cells, lack of a distinct basement membrane or degenerate oocytes) were excluded from the study. Ovarian sections from a minimum of eight animals, including at least three lambs and three adults, were examined for each gene studied. In addition, each follicle class was observed in a minimum of three animals. No differences in expression patterns between lamb and adults ovaries were noted in this study.
Granulosa cell culture
Ovaries were collected from ewes following slaughter at the local abattoir, transported back to the laboratory at room temperature, washed in 3% bleach solution in PBS for 5 minutes, rinsed twice in PBS and stored in Leibovitz media containing 0.1% BSA, 100 U/ml penicillin and 100 μg/ml streptomycin. Follicles approximately 1–2 mm in diameter were dissected away from the ovaries and stored in Leibovitz media until collection of granulosa cells. The granulosa cells were collected by cutting follicles in half followed by manual scraping of cells from the follicular wall using a wire loop. Oocytes and follicular debris were removed from the cells using a micro-glass pipette. Remaining cells were collected by centrifugation at 300 g for 5 min at room temperature, washed once in 5 mls Leibovitz media, twice in 5 mls McCoys media (Sigma, Auckland, New Zealand) with 100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM GlutaMAX-1 and resuspended using a syringe and needle. Cell viability was determined using trypan blue exclusion and 100,000 viable cells per well (250 μl total volume) were added in McCoys media containing 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM GlutaMAX-1, 5 ng/ml selenium (Sigma), 10 ng/ml insulin (Sigma), 5 μg/ml apo-transferrin (Sigma), 30 ng/ml androstenedione (Sigma), 3 ng/ml ovine FSH (purified in our laboratory; 1.4 X USDA-oFSH-19-SIAFP RP2), 1 ng/ml IGF-1 (Long-R3, GroPep, Adelaide, SA 5000, Australia) with varying doses (0–10 ng/ml) of purified human TGF-β1 and recombinant human TGF-β2 (R & D Systems, Minneapolis, MN). Cells were cultured at 37°C in a 5% CO2 incubator. Every 48 hours, 200 μl of media was removed from each well and replaced with 200 μl of warmed media that had been prepared at the start of the culture and stored at 4°C. Media samples from the last 48 hours of treatment were collected on day 6 of treatment and frozen at -20°C for later determination of progesterone concentrations by RIA. Unattached cells were removed by 2 washes with McCoys media at 37°C. Attached cells were lysed by incubating cells at 37°C in 100 μl distilled water for 1–2 hours followed by freezing at -70°C. All treatments were performed at least in triplicate with three independent pools of granulosa cells. Within an assay, individual values outside of 20% of the mean value for the treatment were discarded. Points in which at least 2 of the replicates were not within 20% of each other were regarded as missing data. This occurred for the 10 ng TGF-β1 measure of DNA in a single pool of granulosa cells.
Measurement of DNA
The amount of DNA present in each well was determined by comparing binding of Hoechst 33258 dye (Sigma, final concentration in well of 10 μg/ml) in samples to calf thymus DNA standard measured with a Wallac 1420 plate reader at 350 nm for excitation and 460 nm for emission. Sensitivity of the assay (+ two SD of control buffer value) was 33 ng per well and the intra- and inter-assay co-efficients of variation (CV), based on variability of the 100, 250, 1000 and 2500 ng standard curve points were 3.9% and 8.8%, respectively. No samples were below the sensitivity of the assay.
Measurement of Progesterone
Concentrations of progesterone in media were determined by RIA as described . The sensitivity of the assay (90% maximum binding) was 13 pg/ml and the intra- and inter-assay CV, averaged for a standard pool sample at approximately 20%, 50% and 80% binding, was 8.3% and 19.7%, respectively. No samples were below the sensitivity of the assay.
Determination of expression of TGFβRII mRNA in cultured granulosa cells
Granulosa cells were collected as described above and either frozen immediately after collection or plated in 6 well culture dishes at a density of 1.0–1.5 × 106 viable cells per well in 2 mls of control (i.e. no TGF-β) culture media described above for 48 hours. At this time, unattached cells were removed by washing the wells twice with PBS. RNA was collected using TRIzol according to the manufacturer's instructions. First strand cDNA was produced from total cellular RNA using the SuperScript™ preamplification system for first strand cDNA synthesis. An initial PCR was performed with 4 week old ovary RNA to obtain the ovine sequence of a region of the TGFβRII gene which spans introns 4 and 5 in the human sequence (AY675319) and a second set of primers was designed based on the ovine sequence (see table 1). Expression of TGFβRII was determined by PCR using the Qiagen Taq PCR core Kit (Biolab Scientific Limited) and the internal ovine primers listed in table 1 with the following conditions: initial denaturing cycle of 3 minutes at 94°C followed by 40 cycles of denaturing at 94°C for 1 minute, annealing at 55°C for 1 minute and extension at 72°C for 2 minutes and a final extension at 72°C for 10 minutes. cDNA generated from a 4 week old lamb ovary was run as a positive control whereas replacement of cDNA with water was used as a negative control. Expression of TGFβRII was assessed by visualization of DNA bands of the correct size following gel electrophoresis. Identity of product was confirmed by sequencing.
Concentration of progesterone per μg DNA was calculated for individual wells before averaging for each treatment within each assay. Points in which at least 2 of the replicates were not within 30% of each other were regarded as missing data. Changes in the concentrations of progesterone in media and DNA content after culture were analysed with the general linear model procedure of SAS. Replicate was included in the model as baseline progesterone and DNA values varied among the granulosa cell pools. Differences between least square means were evaluated using least significant differences and were considered significant when p < 0.05. Data presented are least square means. The standard errors of least square means were 0.7 ng/well, 0.2 μg/well and 0.5 ng/μg for progesterone, DNA and p4 per DNA, respectively.
In situ hybridization
The mRNA for TGF-β1 was not observed in granulosa cells or oocytes of any follicles (Figure 1a,1b, table 2). However, TGF-β1 mRNA was observed in stromal and/or thecal cells of type 3 follicles, in the theca interna of type 4 and 5 follicles and also in the stroma and cells of the vascular system. Within the theca interna, the cells closest to the basement membrane usually had more intense signal than those further away (Figure 1a,1b).
The pattern of expression of mRNA encoding TGF-β2 was similar to that observed for TGF-β1, with hybridization limited to the thecal cells of type 3 and larger follicles (Figure 1c,1d, table 2). However, hybridization within the thecal layer appeared evenly distributed in contrast to the signal for TGF-β1 (compare panels a, b and c, d in Figure 1). Expression of TGF-β2 mRNA was also observed in some surface epithelium and stromal cells as well as cells associated with the vascular system.
Expression of TGF-β3 mRNA was exclusive to cells associated with the vascular system of the ovary. Expression was not observed in the granulosa, theca, or oocyte of any follicle examined (Figure 1e,1f,1g,1h,1i, table 2).
Expression of TGFβRI mRNA was observed in oocytes of all types of follicles (Figure 2a,2b,2c,2d, table 2). Granulosa and thecal cells of type 3 and larger follicles also expressed TGFβRI mRNA (Figure 2c,2d). Signal was also observed in the surface epithelium, stromal cells (Figure 2a,2b,2c,2d and luteal tissue (data not shown).
Expression of TGFβRII mRNA was not observed in types 1,1a or 2 follicles (Figure 2e,2f,2g,2h, table 2). Also, in larger follicles TGFβRII mRNA was not detected in granulosa cells or oocytes (Figure 2e,2f,2g,2h). In type 3 and larger follicles, expression of TGFβRII was localized to the theca interna (Figure 2e,2f,2g,2h, table 2). As was observed with TGF-β1, expression of TGFβRII within the theca was most intense in the cells adjacent to the basement membrane (Figure 2e,2f,2g,2h). Signal was also observed in some cells of the surface epithelium (Figure 2e,2f), and in stroma (Figure 2e,2f,2g,2h) and luteal tissue (data not shown).
Effects of TGF-βs on granulosa cell function in vitro and expression of TGFBRII in cultured cells
Both TGF-β1 and TGF-β2 inhibited progesterone synthesis of cultured granulosa cells, whether expressed as a function of number of cells placed in culture (Figure 3, top panel) or as a function of DNA content at the end of culture (Figure 3, bottom panel) with significant affects observed with as little as 0.1 ng/ml of either TGF-β. Treatment with either TGF-β also reduced DNA content at the termination of culture (Figure 3, middle panel). For both variables, no differences were observed between the effect of TGF-β1 and TGF-β2 at any dose of growth factor tested. In contrast to the lack of detectable expression of the TGFβRII mRNA observed in situ, freshly isolated or cultured granulosa cells expressed mRNA for the TGFβRII when assessed by RT-PCR (Figure 4).
In the ewe, expression of TGF-β1 and TGF-β2 mRNA in the follicle was limited to thecal cells during all stages of follicular growth examined. Furthermore, expression of TGF-β3 mRNA was not observed in any follicular cells. This is in contrast to the observed expression patterns for these proteins in other species where TGF-β1 and TGF-β2 have been localized to granulosa as well as thecal cells and sometimes also to the oocytes of many species [8, 12, 13, 31–33]. Also in contrast to sheep, expression of TGF-β3 in cattle and cats was observed in the oocyte, theca and granulosa of follicles at various stages of development [12, 13]. In pigs, the theca interna has been proposed to be the major source of TGF-β since granulosa cells express TGF-β1 mRNA without seeming to make the protein . Similarly, expression of TGF-β2 mRNA has been observed in bovine oocytes, but no detectable TGF-β activity was observed , although other studies have demonstrated TGF-β protein in the oocytes using immunocytochemistry . In addition, granulosa cells isolated from pigs and cattle produce little if any TGFβ bioactivity when cultured in vitro [9, 11]. Thus, it seems likely that in some species, follicular TGF-β activity originates primarily from the thecal cells, with control of activity possibly occurring at several levels including gene transcription (this study), protein translation  or activation of the protein .
Similar to what has been observed in other species [32, 34, 35], expression of TGFβRI mRNA was observed in several different cell-types of the sheep ovary including the oocyte, granulosa cells, thecal cells, stroma, luteal cells and surface epithelium. While expression of TGFβRII mRNA was also observed in stroma, luteal cells and the surface epithelium, its expression within the follicle was limited to the theca. A similar pattern of expression for the TGFβRII mRNA was observed in mouse follicles, with expression most prominent in the theca and barely detectable in granulosa cells . However, using immunocytochemistry, strong staining for TGFβRII has been observed in granulosa cells with no to little staining in oocytes and in the theca in other species [13, 32, 35–37]. The reasons for these observed differences in localization of the TGFβRII are uncertain but may be due to differences in techniques or species differences.
Expression of mRNA encoding all three TGF-β isoforms and the TGF-β type I and II receptors were observed in cells associated with blood vessels and both receptor types and TGF-β1 and 2 mRNAs were observed in the stroma surrounding follicles indicating a potential role for TGF-β in regulating certain functions in the ovarian stroma and vascular network. TGF-β is known to be important in regulating angiogenesis [38, 39]. Moreover, in the ovary, both TGF-β1 and TGF-β3 mRNAs are upregulated during revascularization following autotransplantation of rat ovaries  further supporting a role for these factors in regulating vascular function.
The much more restricted pattern of expression of TGFβRII mRNA in sheep indicates that the TGFβRI may well be involved with other type II receptors in the signalling of other members of the transforming growth factor family. In agreement with this, TGFβRI has recently been shown to be involved in signalling of the oocyte-derived GDF-9 along with BMPRII [41, 42]. In other species, GDF-9 has been shown to regulate granulosa cell mitosis and differentiation  and has been shown to be essential for normal follicular growth and development in both mice  and sheep [44, 45]. Thus, expression of TGFβRI mRNA as well as BMPRII [46, 47] in granulosa cells is probably mediating the effects of GDF-9. Localization of both of these receptors in granulosa cells from the type 3 (secondary) stage of development onwards is consistent with the presence of normal primary but not secondary follicles in both sheep  and mice  lacking biologically active GDF-9. Interestingly, in sheep, TGFβRI mRNA and BMPRII [46, 47] are also both localized in oocytes from the type 1 (primordial) stage onwards suggesting that GDF-9 may also regulate oocyte function in this species.
The suppression of progesterone production and DNA content in granulosa cell cultures by TGF-β1 or TGF-β2 is similar to inhibitory to mild stimulatory effects observed in bovine, ovine and porcine granulosa cell cultures and contrary to the strong stimulatory effects observed in rodents [11, 14–18, 20–26]. The decreased DNA content observed following treatment accounts for some, but not all, of the decrease observed in progesterone concentration in the granulosa cell cultures. The suppression of progesterone synthesis indicates an anti-differentiative role for this growth factor as has been observed for other members of the TGF-β superfamily. The decreased content of DNA observed following culture could be related to a suppression of granulosa cell proliferation or survival. Since TGF-β can stimulate apoptotic pathways in concert with other factors [48, 49], a role for TGF-β in regulating apoptosis of ovarian cells has been proposed.
No differences in the efficacy of TGF-β1 and TGF-β2 were observed in ovine granulosa cells. Similarly, TGF-β1 and TGF-β2 were equally efficacious in stimulating inhibin production in luteinized human granulosa cells  and in modulating gonadotrophin receptor expression in both rat and porcine granulosa cells . Interestingly, while both TGF-β1 and TGF-β2 mRNA were synthesized by the theca interna, their spatial patterning within the theca was quite different. TGF-β1 mRNA was concentrated in the thecal cells closest to the basement membrane, similar to the localization observed for the TGFβRII mRNA. In contrast, TGF-β2 mRNA expression was observed throughout the thecal layer. The role, if any, of the apparent differential regulation of these two isoforms in subtypes of thecal cells is currently unknown.
Given the potent effects of both TGF-β1 and TGF-β2 on granulosa cell function in vitro, the lack of detectable expression of TGFβRII mRNA in these cells using in situ hybridization was very surprising. There are several potential explanations for these apparent conflicting results. It is possible that TGFβRII is expressed in ovine granulosa cells and the technique utilized simply failed to detect this message. The detection of mRNA encoding TGFβRII in isolated granulosa cells both before and after culture using RT-PCR would seem to support this assumption. However, it is possible that the isolation and culture of the granulosa cells potentially could be inducing expression of TGFβRII as most all cells in culture express TGFβRII . In addition, strong expression of TGFβRII mRNA in luteal tissue is also consistent with up regulation of the TGFβRII in these cells as induction of progesterone synthesis by the ovine granulosa cells can be considered to indicate at least a partial luteinization of these cells. Finally, it is also possible that TGFβs are using another member of the type II receptor family to mediate their effects. The existence of a second type II receptor capable of mediating TGF-β effects is supported by the inability of cell lines expressing TGFβRII to bind to TGFβ2 but not TGFβ1  and cell lines responsive to TGF-β without a detectible type II TGFβR .
Expression of mRNAs encoding TGF-β1 and TGF-β2 as well as both type I and II TGF-β receptors were observed in the theca of small growing follicles indicating that TGF-βs may be regulating thecal cell function in an autocrine manner. Expression of mRNA encoding TGF-β type I and II receptors is also observed in luteal cells, stroma, the vascular system and surface epithelium suggesting that TGF-βs may also regulate other cell types in the sheep ovary. Since granulosa cells showed no evidence of expressing any of the TGF-β ligands and expression of the TGF-β type II receptor was equivocal, it seems likely that any TGF-β effects in granulosa cells in vivo are due to paracrine or endocrine actions and possibly regulated through an alternative type II receptor.
Knight PG, Glister C: Local roles of TGF-beta superfamily members in the control of ovarian follicle development. Anim Reprod Sci. 2003, 78: 165-183. 10.1016/S0378-4320(03)00089-7.
Chang H, Brown CW, Matzuk MM: Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002, 23: 787-823. 10.1210/er.2002-0003.
Welt C, Sidis Y, Keutmann H, Schneyer A: Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood). 2002, 227: 724-752.
Durlinger AL, Visser JA, Themmen AP: Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002, 124: 601-609. 10.1530/rep.0.1240601.
Lin SY, Morrison JR, Phillips DJ, de Kretser DM: Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction. 2003, 126: 133-148. 10.1530/rep.0.1260133.
Shimasaki S, Moore RK, Otsuka F, Erickson GF: The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004, 25: 72-101. 10.1210/er.2003-0007.
Chegini N, Williams RS: Immunocytochemical localization of transforming growth factors (TGFs) TGF-alpha and TGF-beta in human ovarian tissues. J Clin Endocrinol Metab. 1992, 74: 973-980. 10.1210/jc.74.5.973.
Schmid P, Cox D, van der Putten H, McMaster GK, Bilbe G: Expression of TGF-beta s and TGF-beta type II receptor mRNAs in mouse folliculogenesis: stored maternal TGF-beta 2 message in oocytes. Biochem Biophys Res Commun. 1994, 201: 649-656. 10.1006/bbrc.1994.1750.
Mulheron GW, Mulheron JG, Danielpour D, Schomberg DW: Porcine granulosa cells do not express transforming growth factor-beta 2 (TGF-beta 2) messenger ribonucleic acid: molecular basis for their inability to produce TGF-beta activity comparable to that of rat granulosa cells. Endocrinology. 1992, 131: 2609-2614. 10.1210/en.131.6.2609.
Roy SK, Hughes J: Ontogeny of granulosa cells in the ovary: lineage-specific expression of transforming growth factor beta 2 and transforming growth factor beta 1. Biol Reprod. 1994, 51: 821-830.
May JV, Stephenson LA, Turzcynski CJ, Fong HW, Mau YH, Davis JS: Transforming growth factor beta expression in the porcine ovary: evidence that theca cells are the major secretory source during antral follicle development. Biol Reprod. 1996, 54: 485-496.
Nilsson EE, Doraiswamy V, Skinner MK: Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development. Mol Reprod Dev. 2003, 66: 237-246. 10.1002/mrd.10350.
Bristol SK, Woodruff TK: Follicle-restricted compartmentalization of transforming growth factor beta superfamily ligands in the feline ovary. Biol Reprod. 2004, 70: 846-859. 10.1095/biolreprod.103.021857.
Dorrington J, Chuma AV, Bendell JJ: Transforming growth factor beta and follicle-stimulating hormone promote rat granulosa cell proliferation. Endocrinology. 1988, 123: 353-359.
Roy SK: Epidermal growth factor and transforming growth factor-beta modulation of follicle-stimulating hormone-induced deoxyribonucleic acid synthesis in hamster preantral and early antral follicles. Biol Reprod. 1993, 48: 552-557.
Saragueta PE, Lanuza GM, Baranao JL: Autocrine role of transforming growth factor beta1 on rat granulosa cell proliferation. Biol Reprod. 2002, 66: 1862-1868.
Gilchrist RB, Morrissey MP, Ritter LJ, Armstrong DT: Comparison of oocyte factors and transforming growth factor-beta in the regulation of DNA synthesis in bovine granulosa cells. Mol Cell Endocrinol. 2003, 201: 87-95. 10.1016/S0303-7207(02)00429-X.
Gangrade BK, May JV: The production of transforming growth factor-beta in the porcine ovary and its secretion in vitro. Endocrinology. 1990, 127: 2372-2380.
May JV, Frost JP, Schomberg DW: Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology. 1988, 123: 168-179.
Skinner MK, Keski-Oja J, Osteen KG, Moses HL: Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology. 1987, 121: 786-792.
Dodson WC, Schomberg DW: The effect of transforming growth factor-beta on follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology. 1987, 120: 512-516.
Knecht M, Feng P, Catt K: Bifunctional role of transforming growth factor-beta during granulosa cell development. Endocrinology. 1987, 120: 1243-1249.
Hutchinson LA, Findlay JK, de Vos FL, Robertson DM: Effects of bovine inhibin, transforming growth factor-beta and bovine Activin-A on granulosa cell differentiation. Biochem Biophys Res Commun. 1987, 146: 1405-1412. 10.1016/0006-291X(87)90806-0.
Mondschein JS, Canning SF, Hammond JM: Effects of transforming growth factor-beta on the production of immunoreactive insulin-like growth factor I and progesterone and on [3H]thymidine incorporation in porcine granulosa cell cultures. Endocrinology. 1988, 123: 1970-1976.
Kubota T, Kamada S, Taguchi M, Aso T: Autocrine/paracrine function of transforming growth factor-beta 1 in porcine granulosa cells. Hum Reprod. 1994, 9: 2118-2122.
Fabre S, Pierre A, Pisselet C, Mulsant P, Lecerf F, Pohl J, Monget P, Monniaux D: The Booroola mutation in sheep is associated with an alteration of the bone morphogenetic protein receptor-IB functionality. J Endocrinol. 2003, 177: 435-444. 10.1677/joe.0.1770435.
McNatty KP, Juengel JL, Wilson T, Galloway SM, Davis GH, Hudson NL, Moeller CL, Cranfield M, Reader KL, Laitinen MP, Groome NP, Sawyer HR, Ritvos O: Oocyte-derived growth factors and ovulation rate in sheep. Reprod Suppl. 2003, 61: 339-351.
Tisdall DJ, Fidler AE, Smith P, Quirke LD, Stent VC, Heath DA, McNatty KP: Stem cell factor and c-kit gene expression and protein localization in the sheep ovary during fetal development. J Reprod Fertil. 1999, 116: 277-291.
Lundy T, Smith P, O'Connell A, Hudson NL, McNatty KP: Populations of granulosa cells in small follicles of the sheep ovary. J Reprod Fertil. 1999, 115: 251-262.
Lun S, Smith P, Lundy T, O'Connell A, Hudson N, McNatty KP: Steroid contents of and steroidogenesis in vitro by the developing gonad and mesonephros around sexual differentiation in fetal sheep. J Reprod Fertil. 1998, 114: 131-139.
Chegini N, Flanders KC: Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology. 1992, 130: 1707-1715. 10.1210/en.130.3.1707.
Juneja SC, Chegini N, Williams RS, Ksander GA: Ovarian intrabursal administration of transforming growth factor beta 1 inhibits follicle rupture in gonadotropin-primed mice. Biol Reprod. 1996, 55: 1444-1451.
Teerds KJ, Dorrington JH: Immunohistochemical localization of transforming growth factor-beta 1 and -beta 2 during follicular development in the adult rat ovary. Mol Cell Endocrinol. 1992, 84: R7-13. 10.1016/0303-7207(92)90085-K.
Qu J, Godin PA, Nisolle M, Donnez J: Expression of receptors for insulin-like growth factor-I and transforming growth factor-beta in human follicles. Mol Hum Reprod. 2000, 6: 137-145. 10.1093/molehr/6.2.137.
Roy SK, Kole AR: Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles. Mol Hum Reprod. 1998, 4: 207-214. 10.1093/molehr/4.3.207.
Roy SK, Kole AR: Transforming growth factor-beta receptor type II expression in the hamster ovary: cellular site(s), biochemical properties, and hormonal regulation. Endocrinology. 1995, 136: 4610-4620. 10.1210/en.136.10.4610.
Wehrenberg U, Giebel J, Rune GM: Possible involvement of transforming growth factor-beta 1 and transforming growth factor-beta receptor type II during luteinization in the marmoset ovary. Tissue Cell. 1998, 30: 360-367.
Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O: Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med. 2003, 47: 149-161.
Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS: Vascular morphogenesis: tales of two syndromes. Hum Mol Genet. 2003, 12 Spec No 1: R97-112. 10.1093/hmg/ddg103.
Dissen GA, Lara HE, Fahrenbach WH, Costa ME, Ojeda SR: Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology. 1994, 134: 1146-1154. 10.1210/en.134.3.1146.
Mazerbourg S, Klein C, Roh J, Kaivo-Oja N, Mottershead DG, Korchynskyi O, Ritvos O, Hsueh AJ: Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol. 2004, 18: 653-665. 10.1210/me.2003-0393.
Vitt UA, Mazerbourg S, Klein C, Hsueh AJ: Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol Reprod. 2002, 67: 473-480.
Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM: Growth differentiation factor-9 is required during early ovarian folliculogenesis [see comments]. Nature. 1996, 383: 531-535. 10.1038/383531a0.
Juengel JL, Hudson NL, Heath DA, Smith P, Reader KL, Lawrence SB, O'Connell AR, Laitinen MP, Cranfield M, Groome NP, Ritvos O, McNatty KP: Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod. 2002, 67: 1777-1789. 10.1095/biolreprod.102.007146.
Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, Galloway SM: Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod. 2004, 70: 900-909. 10.1095/biolreprod.103.023093.
Wilson T, Wu XY, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O'Connell AR, McNatty KP, Montgomery GW: Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod. 2001, 64: 1225-1235.
Souza CJ, Campbell BK, McNeilly AS, Baird DT: Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction. 2002, 123: 363-369. 10.1530/rep.0.1230363.
Foghi A, Teerds KJ, van der Donk H, Moore NC, Dorrington J: Induction of apoptosis in thecal/interstitial cells: action of transforming growth factor (TGF) alpha plus TGF beta on bcl-2 and interleukin-1 beta-converting enzyme. J Endocrinol. 1998, 157: 489-494. 10.1677/joe.0.1570489.
Foghi A, Teerds KJ, van der Donk H, Dorrington J: Induction of apoptosis in rat thecal/interstitial cells by transforming growth factor alpha plus transforming growth factor beta in vitro. J Endocrinol. 1997, 153: 169-178. 10.1677/joe.0.1530169.
Eramaa M, Ritvos O: Transforming growth factor-beta 1 and -beta 2 induce inhibin and activin beta B-subunit messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Fertil Steril. 1996, 65: 954-960.
Gitay-Goren H, Kim IC, Miggans ST, Schomberg DW: Transforming growth factor beta modulates gonadotropin receptor expression in porcine and rat granulosa cells differently. Biol Reprod. 1993, 48: 1284-1289.
Massague J: The transforming growth factor-beta family. Annu Rev Cell Biol. 1990, 6: 597-641.
Lawler S, Candia AF, Ebner R, Shum L, Lopez AR, Moses HL, Wright CV, Derynck R: The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1. Development. 1994, 120: 165-175.
Supported by New Zealand Foundation for Research, Science and Technology, the Royal Society of New Zealand Marsden Fund and Ovita Limited, Dunedin, New Zealand. The authors would also like to thank Doug Jensen for the help with animal care, Lee-Ann Still, Peter Smith and Norma Hudson for technical assistance and Alan Barkus for help with preparation of the figures.
AHB, LDQ and LJH cloned the ovine TGF-βs and receptors, completed sequencing projects and alignments, and performed the in situ hybridizations and PCRs. SL and KLR performed the granulosa cell bioassays including progesterone and DNA measurements. JLJ and KPM designed and co-ordinated the experiments, performed statistical analysis and drafted the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Juengel, J.L., Bibby, A.H., Reader, K.L. et al. The role of transforming growth factor-beta (TGF-beta) during ovarian follicular development in sheep. Reprod Biol Endocrinol 2, 78 (2004). https://doi.org/10.1186/1477-7827-2-78
- Granulosa Cell
- Luteal Cell
- Large Follicle
- Thecal Cell
- Luteal Tissue